Efoglim MV 2mg/500mg/0.3mg Tablet SR
Marketer
Oldmed Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Efoglim MV 2mg/500mg/0.3mg Tablet SR
Diabetic patients often utilize the anti-diabetic medication, Efoglim MV 2mg/500mg/0.3mg Tablet SR, a combination drug for managing type 2 diabetes in adults. This medicine helps regulate blood sugar. Administer this extended-release tablet with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose readings. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's crucial to combine this medication with a healthy diet, regular exercise, and weight management as directed by your doctor for comprehensive diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn its symptoms (sweating, dizziness, headache, trembling) and management. Maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before starting treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood sugar monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Efoglim MV 2mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Efoglim MV 2mg/500mg/0.3mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Efoglim MV 2mg/500mg/0.3mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer on an empty stomach.
Common Side effects of Efoglim MV 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Efoglim MV 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Efoglim MV 2mg/500mg/0.3mg Extended-Release Tablets should be taken on an empty stomach.
How Efoglim MV 2mg/500mg/0.3mg Tablet SR works:
Extended-release Efoglim MV tablets (2mg/500mg/0.3mg) combine three distinct anti-diabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Efoglim MV 2mg/500mg/0.3mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Efoglim MV 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Efoglim MV 2mg/500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Efoglim MV 2mg/500mg/0.3mg Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Efoglim MV 2mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A reduced initial dosage is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, it's contraindicated in those with severe liver disease.
What if you forget to take Efoglim MV 2mg/500mg/0.3mg Tablet SR :
Should you forget a dose of Efoglim MV 2mg/500mg/0.3mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Efoglim MV 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently